Senior Scientific, LLC a Manhattan Scientifics funded company has recently developed highly precise magnetic cell measurement device that is useful for determining the progress of cancer treatment. The company is looking for commercialization of its novel nano-electromagnetic sensing technology.
According to the Senior Scientific, the new device is able to accurately monitor the tumor cells in leukemia as well as solid tumors including breast cancer and it can report the accurate guidance to the doctors whether the cancer cells has disappeared or not during treatment. This can help doctors in determining the next course of action of treatment and also the right amount of therapy and thus the side effects with the overuse of therapy can also be minimized.
The technique uses a magnetic needle with targeted magnetic nanoparticle that determines the minimum residual disease. The information might help doctors for taking appropriate treatment including repeating treatment in case of recurrence. The present biopsy for detecting leukemia cells fails to detect the disease if the cells are less than 5% of the sample, however with the newly developed device, the MRD can be detected down to 0.3% of level, which is a great level of sensitivity.